Digital Health Startups

ForPhysician is an AI-powered medical diagnostic support platform that provides physicians with preliminary analysis and evidence-based recommendations for clinical cases, which are then verified by specialist physicians before delivery.

2 investors

Force Therapeutics provides a digital patient engagement platform that offers personalized patient education, remote monitoring, and care coordination tools, including patient-reported outcome measures (PROMs) collection. It serves healthcare organizations aiming to improve care outcomes.

2 investors

Formula Health is a prescription management and fulfillment platform that helps medical practices prescribe compounded therapeutics such as GLP-1s, peptides, hormone replacement therapy, and personalized supplements. It automates order routing across licensed 503A and 503B pharmacies, subscription billing, refills, and shipping notifications for clinicians and their patients.

2 investors

Fortified Health Security provides cybersecurity services tailored to protect health systems and patients from cyber threats, with expertise in healthcare-specific IT complexities. The company serves healthcare organizations across the United States and combines risk management strategies with advanced technologies to address compliance and security challenges.

2 investors

Fovionics develops smart glasses for blind and visually impaired people, aimed at assisting with reading and daily tasks. The company focuses on making assistive vision technology affordable, with roots addressing accessibility gaps in Brazil.

2 investors

Foxo offers a precision longevity program combining systems-biology diagnostics, biomarker and ageing-clock testing, AI-driven personalization, lifestyle and therapeutic interventions, and healthspan coaching. It targets biological ageing at the cellular level to help individuals extend healthspan and maintain cognitive and physical performance.

2 investors

Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System. It plans to expand into bladder and kidney cancer applications, aiming to reduce the side effects associated with conventional prostate treatments.

2 investors

Free to Feed provides consulting and advisory support to help parents meet their infant feeding goals. The company operates in the digital health and wellness space focused on feeding support.

2 investors

Freed builds an AI assistant for clinicians that generates clinical notes from patient encounters, offering customizable templates, visit prep summaries, patient-friendly instructions, referral and other letters, and suggested billable ICD-10, CPT, and E/M codes that can sync to an EHR. It serves healthcare providers looking to reduce documentation time.

2 investors

Frontera Health develops AI technology for Applied Behavior Analysis (ABA) that helps BCBAs and clinics work more efficiently and treat more children diagnosed with autism. The tools aim to increase patient access, improve clinic operations, and support more precise treatment plans for children and their families in the United States.

2 investors

Frontier provides employers with integrated healthcare solutions including primary care clinics, specialty care coordination with transparent pricing, and discounted medication management. The company serves corporate employers seeking to reduce healthcare costs and improve employee access to care.

2 investors

Fundamental VR develops immersive extended reality (XR) training solutions for clinical and medical device professionals, enabling faster skill acquisition and competency development through interactive 3D simulations and digital twins of medical procedures.

2 investors

Fusion Genomics' ONETest platform integrates targeted metagenomic sequencing with artificial intelligence-driven analysis to identify microbial pathogens from clinical specimens, serving hospital laboratories and critical-care teams for complex infection diagnosis.

2 investors

FUS Mobile develops the Neurolyser XR, a non-invasive medical device that uses high intensity focused ultrasound (HIFU) with fluoroscopic guidance to thermally ablate the lumbar medial branch nerve for treating chronic facet-mediated low back pain. It is intended for interventional pain management physicians and is approved in Europe and has US De Novo marketing authorization.

2 investors

Future Cardia develops an implantable, under-the-skin cardiac monitor placed via a short office procedure for long-term monitoring of patients with arrhythmias and heart failure. The device is a Class II, 510(k) product aimed at chronic heart failure management and existing reimbursement structures.

2 investors

GLNK provides healthcare data intelligence for life sciences organizations, offering profiles of healthcare providers, institutional data, payments tracking, medical device utilization metrics, and prescribing patterns across the US healthcare ecosystem.

2 investors

Gain Therapeutics is a biotechnology company that develops small molecule drugs targeting allosteric binding sites on disease-related proteins, using its computational Magellan platform to discover compounds that stabilize or destabilize proteins to treat central nervous system disorders, lysosomal storage diseases, metabolic disorders, and oncology; its lead candidate GT-02287 is in Phase 1b testing for Parkinson's disease.

2 investors

GalenusCare (ChorusRx) provides precision pharmacy services for PACE and hospice care programs, combining clinical pharmacists with AI-powered analytics to optimize medication regimens, reduce adverse drug events, and lower medical costs. Its services include medication regimen optimization, precision compliance packaging, symptom kits, and collaborative pharmacy management with value-based care agreements.

2 investors

Gardia offers a wearable emergency-call wristband with automatic fall detection, a built-in mobile connection, GPS, and speaker/microphone, plus a companion app for family members and an optional connection to a 24/7 professional emergency call center. It targets older and at-risk adults and their relatives in Germany, and helps customers claim reimbursement of service costs through nursing care insurance (Pflegekasse).

2 investors

GattaCo develops a blood plasma separator device that enables point-of-care collection and transport of lab-quality plasma for remote blood testing and monitoring. The A-PON Plasma Separator uses passive elution technology to extract plasma from finger-stick blood samples for later laboratory analysis.

2 investors

Gelesis develops an oral superabsorbent hydrogel platform (OHS) built from naturally derived materials that works locally in the GI tract to influence satiety signals and support metabolic health. Its product Plenity is a clinically studied aid for weight management in overweight or obese adults with a BMI of 25 to 40 when combined with diet and exercise.

2 investors

Gene S is an Australian biotechnology company providing Next Generation Sequencing solutions and gene testing software to laboratories and healthcare providers for delivering pharmacogenomic results.

2 investors

Genedrive Diagnostics develops and commercialises a rapid point-of-care pharmacogenetic testing platform that detects genetic variants to guide personalised medicine decisions in emergency healthcare. The UK-based company's tests help clinicians tailor drug choices based on a patient's genetics.

2 investors

GenEmbryomics provides comprehensive preimplantation genetic screening of IVF embryos using whole genome sequencing, screening for chromosome abnormalities, mosaicism, and thousands of inherited and new genetic mutations. It serves patients and families undergoing IVF, delivering reports to help select embryos with the lowest genetic disease risk.

2 investors